Chris Delporte10.06.10
Privately held Argon Medical Devices Inc. has acquired the pressure monitoring and catheter product lines from Franklin Lake, N.J.-based Becton, Dickinson & Co. (BD).
The purchase included BD’s blood pressure monitoring devices and central venous, pulmonary artery and extended dwell catheters. For Athens, Texas-based Argon, the deal expands its interventional radiology, critical care and cardiac catheterization product lines. As part of the deal, Argon also acquired one of BD’s manufacturing facility in Singapore. Argon manufactures its other products in Athens.
According to Argon executives, the acquisition of the critical care and extended dwell catheter product platforms helps to strength its line of vascular access devices by joining Argon's other products, including its Cleaner Rotational Thrombectomy System, JAWZ Endomyocardial Biopsy Forceps, pressure transducers, high-pressure manifolds and vascular introducer kits.
The company's products are sold through a combination of direct sales representatives and specialty distributors in the United States and a network of international distributors.
"The BD pressure monitoring and catheter products are well recognized by hospitals and physicians worldwide," said Michael J. Hudson, CEO of Argon. "The acquisition of these well-recognized products rounds out the Argon portfolio giving us a significant global presence in these important markets."
The purchase included BD’s blood pressure monitoring devices and central venous, pulmonary artery and extended dwell catheters. For Athens, Texas-based Argon, the deal expands its interventional radiology, critical care and cardiac catheterization product lines. As part of the deal, Argon also acquired one of BD’s manufacturing facility in Singapore. Argon manufactures its other products in Athens.
According to Argon executives, the acquisition of the critical care and extended dwell catheter product platforms helps to strength its line of vascular access devices by joining Argon's other products, including its Cleaner Rotational Thrombectomy System, JAWZ Endomyocardial Biopsy Forceps, pressure transducers, high-pressure manifolds and vascular introducer kits.
The company's products are sold through a combination of direct sales representatives and specialty distributors in the United States and a network of international distributors.
"The BD pressure monitoring and catheter products are well recognized by hospitals and physicians worldwide," said Michael J. Hudson, CEO of Argon. "The acquisition of these well-recognized products rounds out the Argon portfolio giving us a significant global presence in these important markets."